Global Point of Care (POC) Lipid Test Market, By Product (Consumables and Instruments), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Tangier Disease, Familial Hypercholesterolemia and Others), Mode (OTC-Based Testing and Prescription-Based Testing), End-User (Hospitals, Clinics, Research and Diagnostic Laboratories and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The point of care (POC) lipid test market is witnessing a surge in its market value over the years and this can be attributed to the rising obesity levels in the consumers. Data Bridge Market Research analyses that the point of care (POC) lipid test market will exhibit a CAGR of around 9.1% for the forecast period of 2021-2028.
Points of care (POC) tests are those medical tests that that help to diagnose the problem in the human body at the given point. This means that unlike other conventional diagnostic tests, the point of care tests help to diagnose the problems within no time and reduce one’s length of stay in the hospital. The point of care tests help to provide real time results within a few minutes. Therefore, a point of care (POC) lipid test is undergone to check the functioning of the lipid in the cells. When the cholesterol spikes up, it affects the functioning of lipid in the body and consequently by lead to grievous illnesses like heart attack, coronary artery disease and so on.
Increase in the investment in healthcare facilities and technologies have led to the rise in demand for point of care (POC) lipid test apparatuses. Another point of care (POC) lipid test market growth driving factors include rising number of patients with diabetes, cardiovascular diseases, obesity etc. A spurt in the awareness regarding the technology has also led to the increase in demand for this technology. Some other market growth driving factors are increasing geriatric population, eco-friendliness of the technology, reduced wastage of time and accuracy of the diagnosed results.
However, increasing cost of point of care (POC) lipid test will act as a restraint to the growth of the market. Also, limited availability of lab services in rural areas especially in the undeveloped countries will further hammer down the market from growing. Lack of trained professionals in these areas will also restrict the scope for market growth.
This point of care (POC) lipid test market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point of care (POC) lipid test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care (POC) Lipid Test Market Scope and Market Size
The point of care (POC) lipid test market is segmented on the basis of product, application, mode and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the point of care (POC) lipid test market is segmented into consumables and instruments.
- On the basis of application, the point of care (POC) lipid test market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others.
- On the basis of mode, the point of care (POC) lipid test market is segmented into OTC-based testing and prescription-based testing.
- The point of care (POC) lipid test market can also be segmented on the basis of end-user into hospitals, clinics, research and diagnostic laboratories and others.
Point of Care (POC) Lipid Test Market Country Level Analysis
The point of care (POC) lipid test market is analysed and market size insights and trends are provided by country, product, application, mode and end-user as referenced above.
The countries covered in the point of care (POC) lipid test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe has emerged to be the dominant region in the point of care (POC) lipid test market owing to the prevalence of high number of patients with cardiovascular diseases. Also, the developed healthcare facilities in the region will enable it to witness significant growth for the forecast period. Asia-Pacific on the contrary will be at the top position to undergo the highest growth rate for the forecast period. The major reason for this being high geriatric population, rising levels of obesity in the individuals and developing healthcare facilities.
The country section of the point of care (POC) lipid test market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The point of care (POC) lipid test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clinical trial imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) lipid test market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point of Care (POC) Lipid Test Market Share Analysis
The point of care (POC) lipid test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care (POC) lipid test market.
The major players covered in the point of care (POC) lipid test market report are Abbott., Abaxis, PTS Diagnostics, F. Hoffmann-La Roche Ltd, Samsung Medison Co., Ltd., Bio-Rad Laboratories, Inc., The Menarini Group, Nova Biomedical, AccuBioTech Co., Ltd., BD, Chembio Diagnostics, Inc., Danaher.,EKF DIAGNOSTICS HOLDINGS PLC, Johnson & Johnson Services, Inc., Quidel Corporation, Sekisui Diagnostics, Siemens, Trinity Biotech Ireland, Shubh Surgical & Pharmaceuticals and Sarita Surgical Works among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Point of Care (PoC) Lipid Test Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.